Director, Global Market Access and Pricing Strategy Oncology - Pumitamig

Director, Global Market Access and Pricing Strategy Oncology – Pumitamig

Working with Us Challenging. Meaningful. Life-changing. Those aren't words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You'll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.

The Director, Market Access Strategy – Oncology (Pumitamig) will be responsible for defining and driving the Global Market Access (GMAx) strategy, including global pricing strategy and governance, for one or more therapeutic areas targeted by Pumitamig, across late‑stage development, launch preparation, and lifecycle planning. The role will ensure that payer, pricing, and evidence considerations are fully integrated into both asset‑level and portfolio‑level decision making. The Director will provide strategic market access leadership and input to Development and Commercial Strategy teams and will represent integrated Global Market Access perspectives in above‑brand portfolio strategy discussions and portfolio prioritisation forums. This role will report into the Senior Director, Market Access Strategy – Oncology, Pumitamig.

The role will also actively engage with regional and local market access stakeholders worldwide to ensure global strategies are robust, coherent, and executable in a rapidly evolving and increasingly challenging access landscape. In the alliance context of the Pumitamig program, this role requires strong leadership and influencing capabilities to navigate parallel organizational structures, foster effective and trust‑based collaboration with BioNTech partners, and engage closely within the joint Pricing and Access Working Group to support aligned strategy development, governance, and execution. The Director will ensure clear articulation and advancement of BMS access strategy priorities while contributing constructively to joint decision‑making in support of shared program objectives. Success in this role requires a motivated, inclusive, and decisive leader with strong global access expertise, a proven ability to navigate complexity, and the confidence to make and communicate difficult strategic trade‑offs. The successful candidate will bring a strong track record of shaping access strategy for oncology assets, influencing senior‑level decision making, and clearly articulating strategic recommendations across functions and levels of the organization.

Responsibilities:

• Lead the development and execution of an integrated Global Market Access and Pricing strategy for one or more therapeutic areas targeted by Pumitamig, spanning late‑stage development, launch, and lifecycle management. This includes shaping global price corridors, access archetypes, and pricing assumptions, and ensuring alignment through appropriate pricing governance and joint alliance forums, while enabling timely and successful first worldwide price negotiations.
• Serve as the Global Market Access lead to the Global Product Team, ensuring payer perspectives are embedded early and consistently into development and commercial strategies, including optimization of registrational trial designs through governance forums (e.g. DEX). Ensure robust, forward‑looking evidence generation plans are in place to meet evolving payer and HTA requirements across key markets.
• Collaborate across the full Global Market Access organization (Pricing, HEOR, regional and local access teams) to holistically assess Pumitamig opportunities, balancing speed to access, sustainability of value, pricing discipline and long‑term franchise considerations, while accounting for anticipated market, policy, and competitive dynamics at launch and beyond.
• Lead the Global Market Access Core Value Team and Value Strategy Team for assigned assets or indications, ensuring alignment across functions and geographies and driving clear strategic direction, prioritization, and execution.
• Partner with Commercial, Medical Affairs, Business Insights & Analytics, and regional teams to continuously monitor the external environment and synthesize insights to inform and adapt Market Access strategy across the asset lifecycle, from late development milestones through commercialization.
• Effectively lead and influence within a highly matrixed and alliance‑based environment, building strong, trust‑based relationships across functions and with BioNTech partners to enable aligned decision‑making, consistent strategy execution, best‑practice sharing, and seamless implementation of Global Market Access initiatives in support of shared program objectives.

Qualifications:

• Bachelor's degree required in a relevant field; advanced degree (e.g. PharmD, MD, PhD, MSc, MBA) preferred.
• Deep understanding of the current and evolving global market access environment for oncology products, including pricing, reimbursement, and HEOR frameworks, and how these can be leveraged to advance differentiated payer value propositions.
• 8+ years of experience in market access, pricing, HEOR, or related roles within the healthcare or biopharmaceutical industry.
• Strong knowledge of the drug development and commercialization process, supported by a solid scientific background or equivalent experience enabling assessment of clinical development plans from a payer perspective. Demonstrated ability to interpret and critically evaluate clinical trial designs, endpoints, and evidence implications for access. Launch and/or late‑stage development experience is strongly preferred.
• Demonstrated business and financial acumen, with the ability to assess complex strategic trade‑offs, synthesize multiple perspectives, and distil clear, pragmatic recommendations to support senior‑level decision‑making.
• Proven ability to clearly and credibly articulate global access strategy to senior, cross‑functional stakeholders, including audiences with varying levels of familiarity with market access dynamics across disease areas or geographies.
• Demonstrated success leading and influencing cross‑functional, matrixed teams, with the confidence and judgment to constructively challenge partners and drive alignment when needed.
• High degree of effectiveness in navigating international, multi‑cultural, and cross‑organizational environments, including experience working across regions and, ideally, within alliance or partnership settings.
• Strong prioritization and execution skills, with experience managing multiple strategic initiatives in parallel while delivering high‑quality outcomes in a timely manner.
• Comfortable operating in a rapidly evolving scientific, competitive, and policy landscape, with the ability to manage ambiguity and adapt strategy as new information emerges.
• Willingness and ability to travel as required to international congresses, alliance interactions, and internal BMS meetings.
• Demonstrates BMS leadership behaviors including Integrity, Inclusion, Accountability, Innovation, Passion, and Speed.